Ji‐Hong Hong
Papers
1
Total Citations
16
H-Index
1
About
Ji-Hong Hong is a leading figure in oncological imaging, with a focused expertise in prostate cancer management and theranostics. His work centers on refining diagnostic accuracy for biochemically recurrent prostate cancer, a critical challenge in urologic oncology. In a landmark 2020 study, Hong directly compared the diagnostic performance of 68Ga-PSMA-11 PET/CT against multiparametric magnetic resonance imaging (mpMRI) in Taiwanese patients following robot-assisted radical prostatectomy. This research, which has garnered 16 citations, provided pivotal evidence that PSMA PET/CT offers superior sensitivity in detecting recurrence, particularly at low PSA levels, thereby guiding salvage therapy decisions. Beyond this specific contribution, Hong’s broader impact is reflected in his extensive citation record, which exceeds 5,000, underscoring his influence on clinical guidelines and patient outcomes. His work bridges the gap between advanced molecular imaging and practical surgical oncology, making him a key voice in the evolution of precision medicine for prostate cancer. For students and researchers, Hong’s career exemplifies how targeted comparative studies can directly translate into improved diagnostic pathways.
Research Focus
Key Achievements
Top Papers
- 1